RAB25 and neoplasm: To verify that the effect observed by cisplatin@CB[7] on the growth of tumours was independent to the route of administration, a fourth group of mice bearing i.p. A2780-Rab25 tumours was injected subcutaneously with cisplatin@CB[7].